Menopause_NN
is_VBZ
associated_VBN
with_IN
a_DT
significant_JJ
increase_NN
in_IN
blood_NN
monocyte_NN
number_NN
and_CC
a_DT
relative_JJ
decrease_NN
in_IN
the_DT
expression_NN
of_IN
estrogen_NN
receptors_NNS
in_IN
human_JJ
peripheral_JJ
monocytes_NNS
._.

PROBLEM_NN
:_:
The_DT
clinical_JJ
significance_NN
of_IN
the_DT
differential_JJ
expression_NN
of_IN
estrogen_NN
receptor_NN
-LRB-_-LRB-
ER_NN
-RRB-_-RRB-
in_IN
human_JJ
monocytes_NNS
was_VBD
evaluated_VBN
._.

METHOD_NN
:_:
Two_CD
color_NN
flow_NN
cytometry_NN
analysis_NN
was_VBD
used_VBN
on_IN
peripheral_JJ
blood_NN
samples_NNS
of_IN
young_JJ
and_CC
postmenopausal_JJ
females_NNS
and_CC
postmenopausal_JJ
females_NNS
treated_VBN
with_IN
estrogen_NN
replacement_NN
therapy_NN
._.

In_IN
addition_NN
,_,
the_DT
monocyte_NN
and_CC
lymphocyte_NN
counts_NNS
and_CC
the_DT
blood_NN
estrogen_NN
levels_NNS
of_IN
each_DT
patient_NN
were_VBD
determine_VBN
._.

RESULTS_NNS
:_:
During_IN
menopause_NN
there_EX
is_VBZ
a_DT
significant_JJ
decrease_NN
in_IN
the_DT
percentage_NN
of_IN
ER_NN
positive_JJ
monocytes_NNS
,_,
and_CC
an_DT
increase_NN
in_IN
blood_NN
monocyte_NN
number_NN
,_,
which_WDT
declines_VBZ
following_VBG
estrogen_NN
replacement_NN
therapy_NN
to_TO
values_NNS
of_IN
the_DT
young_JJ
._.

CONCLUSIONS_NNS
:_:
These_DT
findings_NNS
suggest_VBP
that_IN
estrogen_NN
modulates_VBZ
the_DT
monocyte_NN
numbers_NNS
and_CC
its_PRP$
effects_NNS
may_MD
be_VB
mediated_VBN
through_IN
the_DT
ER_NN
in_IN
the_DT
monocytes_NNS
._.

